Lupus Nephritis Features
Do you think patients with lupus nephritis can be good renal transplant candidates if their disease has been quiescent for at least one year?
In a recent study researchers examined transplant outcomes in patients with lupus nephritis who had no clinical evidence of disease in the year prior.
Latest Lupus Nephritis News
Minority race/ethnicity and lack of private insurance associated with inadequate care in U.S.
The risk of end-stage renal disease in patients with systemic lupus erythematosus may even be declining, but outcomes differ by race.
The condition appears to be associated with high hospitalization and death rates, researchers reported.
Half of those lupus nephritis patients taking three medications achieved full remission.
A plant-based compound could provide a new treatment for lupus nephritis with fewer side effects.
Large study looked at matched pairs of lupus patients with renal disease starting dialysis with hemodialysis or peritoneal dialysis.
With systemic lupus erythematosus, kidney disease reduces life expectancy an average of 15 years
Predictors of moderate-severe SLE flare at week 52 identified using three indicators
A 50% or greater reduction in proteinuria after six months of treatment for severe lupus nephritis predicted better 15-year renal survival.
Lupus nephritis patients can be good candidates if their disease is quiescent for at least one year prior to surgery.
SLE patients with renal failure often continue to experience flares, but most commonly these are serologic rather than clinical.
If a lupus patient has never had renal disease, pregnancy, in and of itself, is not likely to increase that risk.
Even partial recovery in lupus nephritis patients lowers the risk of needing dialysis or a kidney transplant.
Effects of MMF may be influenced by the pathogenesis and/or cellular micro-environments unique to each disease process.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Prepping Your Practice for Retirement
- Support for Adjuvant Chemotherapy in Nonmetastatic Bladder Cancer
- Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa
- Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival
- Early Bicalutamide Aids Survival in Nonmetastatic Prostate Cancer